<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28094303</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2017</Year><Month>Jan</Month><Day>17</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Genetic Polymorphisms of rs3077 and rs9277535 in HLA-DP associated with Systemic lupus erythematosus in a Chinese population.</ArticleTitle><Pagination><StartPage>39757</StartPage><MedlinePgn>39757</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">39757</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep39757</ELocationID><Abstract><AbstractText>Although the SLE risk gene loci of HLA-DR and HLA-DQ within the major histocompatibility complex (MHC) region has been gradually revealed by recent Genome-Wide Association studies (GWAS), the association of HLA-DP polymorphisms with SLE was minimally reported. Considering that the variants in rs3077 and rs9277535 in the HLA-DP region could influence the immune response by affecting antigen presentation of HLA class II molecules to CD4<sup>+</sup> T cells, the present study aimed to explore the role of HLA-DP polymorphisms in SLE. In total, samples from 335 SLE patients and 635 healthy controls were collected and genotyped by a polymerase chain reaction-high resolution melting (PCR-HRM) assay. A significant positive correlation was observed between the SNP rs3077, rs9277535 of HLA-DP and SLE susceptibility (rs3077, OR&#x2009;=&#x2009;0.74, 95%CI&#x2009;=&#x2009;0.60-0.91, P&#x2009;=&#x2009;0.004; rs9277535, OR&#x2009;=&#x2009;0.72, 95%CI&#x2009;=&#x2009;0.59-0.88, P&#x2009;=&#x2009;0.001). Rs3077 polymorphism was corelated to IL-17, INF-&#x3b3; and cutaneous vasculitis (P&#x2009;=&#x2009;0.037, P&#x2009;=&#x2009;0.020 and P&#x2009;=&#x2009;0.006, respectively). Additionally, rs3077 AA genotype carriers showed lower concentration of inflammatory cytokines and lower cutaneous vasculitis incidence than did the other two genotype. No significant association was observed between rs9277535 and cytokines or any clinical features. In conclusion, HLA-DP polymorphisms (rs3077 and rs9277535) were associated with SLE susceptibility and the levels of some inflammatory cytokines in SLE patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Junlong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Wenli</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Anning</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yongkang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Bei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lanlan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006682">HLA-DP Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006682" MajorTopicYN="N">HLA-DP Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014657" MajorTopicYN="N">Vasculitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28094303</ArticleId><ArticleId IdType="pmc">PMC5240340</ArticleId><ArticleId IdType="doi">10.1038/srep39757</ArticleId><ArticleId IdType="pii">srep39757</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu T. Y., Tam L. S. &amp; Li E. K. Labour and non-labour market productivity in Chinese patients with systemic lupus erythematosus. Rheumatology 51, 284&#x2013;292, doi: 10.1093/rheumatology/ker247 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ker247</ArticleId><ArticleId IdType="pubmed">21752871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees F. et al.. Mortality in systemic lupus erythematosus in the United Kingdom 1999&#x2013;2012. Rheumatology, kev424, doi: 10.1093/rheumatology/kev424 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kev424</ArticleId><ArticleId IdType="pubmed">26748350</ArticleId></ArticleIdList></Reference><Reference><Citation>Holloway L. et al.. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcomes 12, 116, doi: 10.1186/s12955-014-0116-1 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-014-0116-1</ArticleId><ArticleId IdType="pmc">PMC4223409</ArticleId><ArticleId IdType="pubmed">25048687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S. S. et al.. The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002&#x2013;2004: The Georgia Lupus Registry. Arthritis &amp; Rheumatology 66, 357&#x2013;368, doi: 10.1002/art.38239 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38239</ArticleId><ArticleId IdType="pmc">PMC4617771</ArticleId><ArticleId IdType="pubmed">24504808</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees F. et al.. The incidence and prevalence of systemic lupus erythematosus in the UK, 1999&#x2013;2012. Annals of the Rheumatic Diseases 75, 136&#x2013;141, doi: 10.1136/annrheumdis-2014-206334 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2014-206334</ArticleId><ArticleId IdType="pmc">PMC4717400</ArticleId><ArticleId IdType="pubmed">25265938</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R. et al.. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology 51, 721&#x2013;729, doi: 10.1093/rheumatology/ker370 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ker370</ArticleId><ArticleId IdType="pubmed">22179737</ArticleId></ArticleIdList></Reference><Reference><Citation>Deapen D. et al.. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35, 311&#x2013;318 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1536669</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n-Segovia D. et al.. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis &amp; Rheumatism 52, 1138&#x2013;1147, doi: 10.1002/art.20999 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20999</ArticleId><ArticleId IdType="pubmed">15818688</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiffin N., Adeyemo A. &amp; Okpechi I. A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus. Orphanet J Rare Dis 8, 2, doi: 10.1186/1750-1172-8-2 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-8-2</ArticleId><ArticleId IdType="pmc">PMC3551738</ArticleId><ArticleId IdType="pubmed">23289717</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y. &amp; Tsao B. P. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nature Reviews Rheumatology 6, 683&#x2013;692, doi: 10.1038/nrrheum.2010.176 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2010.176</ArticleId><ArticleId IdType="pmc">PMC3135416</ArticleId><ArticleId IdType="pubmed">21060334</ArticleId></ArticleIdList></Reference><Reference><Citation>Gateva V. et al.. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nature Genetics 41, 1228&#x2013;1233, doi: 10.1038/ng.468 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.468</ArticleId><ArticleId IdType="pmc">PMC2925843</ArticleId><ArticleId IdType="pubmed">19838195</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J.-W. et al.. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature Genetics 41, 1234&#x2013;1237, doi: 10.1038/ng.472 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.472</ArticleId><ArticleId IdType="pubmed">19838193</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W. et al.. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 6, e1000841, doi: 10.1371/journal.pgen.1000841 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000841</ArticleId><ArticleId IdType="pmc">PMC2820522</ArticleId><ArticleId IdType="pubmed">20169177</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C. et al.. Differential Responses to Smith D Autoantigen by Mice with HLA-DR and HLA-DQ Transgenes: Dominant Responses by HLA-DR3 Transgenic Mice with Diversification of Autoantibodies to Small Nuclear Ribonucleoprotein, Double-Stranded DNA, and Nuclear Antigens. The Journal of Immunology 184, 1085&#x2013;1091, doi: 10.4049/jimmunol.0902670 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902670</ArticleId><ArticleId IdType="pmc">PMC2842881</ArticleId><ArticleId IdType="pubmed">20007529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K. et al.. The HLA-DRbeta1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations. Nat Commun 5, 5902, doi: 10.1038/ncomms6902 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6902</ArticleId><ArticleId IdType="pubmed">25533202</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando M. M. et al.. Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Annals of the rheumatic diseases 71, 777&#x2013;784, doi: 10.1136/annrheumdis-2011-200808 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2011-200808</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa H. et al.. Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients. PloS one 8, e53910, doi: 10.1371/journal.pone.0053910 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0053910</ArticleId><ArticleId IdType="pmc">PMC3540046</ArticleId><ArticleId IdType="pubmed">23320107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X. M. et al.. Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations. Mult Scler 15, 1422&#x2013;1430, doi: 10.1177/1352458509345905 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458509345905</ArticleId><ArticleId IdType="pubmed">19965521</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieczorek S., Holle J. U. &amp; Epplen J. T. Recent progress in the genetics of Wegener&#x2019;s granulomatosis and Churg&#x2013;Strauss syndrome. Current Opinion in Rheumatology 22, 8&#x2013;14, doi: 10.1097/BOR.0b013e3283331151 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e3283331151</ArticleId><ArticleId IdType="pubmed">19864953</ArticleId></ArticleIdList></Reference><Reference><Citation>Radstake T. R. D. J. et al.. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nature Genetics 42, 426&#x2013;429, doi: 10.1038/ng.565 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.565</ArticleId><ArticleId IdType="pmc">PMC2861917</ArticleId><ArticleId IdType="pubmed">20383147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamatani Y. et al.. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nature Genetics 41, 591&#x2013;595, doi: 10.1038/ng.348 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.348</ArticleId><ArticleId IdType="pubmed">19349983</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat R. M., Mohamed S. F., Bassyouni I. H. &amp; Raouf A. A. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity. Cytokine 72, 146&#x2013;153, doi: 10.1016/j.cyto.2014.12.027 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2014.12.027</ArticleId><ArticleId IdType="pubmed">25647269</ArticleId></ArticleIdList></Reference><Reference><Citation>He S.-j. et al.. Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB&#xd7;NZW F1 mice via interference with TLR-mediated APC response. Acta Pharmacologica Sinica 35, 219&#x2013;229, doi: 10.1038/aps.2013.167 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2013.167</ArticleId><ArticleId IdType="pmc">PMC4651227</ArticleId><ArticleId IdType="pubmed">24374810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghodke-Puranik Y. &amp; Niewold T. B. Immunogenetics of systemic lupus erythematosus: A comprehensive review. J Autoimmun 64, 125&#x2013;136, doi: 10.1016/j.jaut.2015.08.004 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4628859</ArticleId><ArticleId IdType="pubmed">26324017</ArticleId></ArticleIdList></Reference><Reference><Citation>Niewold T. B. Advances in lupus genetics. Curr Opin Rheumatol 27, 440&#x2013;447, doi: 10.1097/bor.0000000000000205 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bor.0000000000000205</ArticleId><ArticleId IdType="pmc">PMC4540605</ArticleId><ArticleId IdType="pubmed">26218512</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y. et al.. Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis. PLoS One 9, e111677, doi: 10.1371/journal.pone.0111677 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111677</ArticleId><ArticleId IdType="pmc">PMC4218798</ArticleId><ArticleId IdType="pubmed">25365208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L. et al.. Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development. Sci Rep 5, 14933, doi: 10.1038/srep14933 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14933</ArticleId><ArticleId IdType="pmc">PMC4604517</ArticleId><ArticleId IdType="pubmed">26462556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez P., Rodriguez-Carrio J., Caminal-Montero L., Mozo L. &amp; Suarez A. A pathogenic IFNalpha, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients. Sci Rep 6, 20651, doi: 10.1038/srep20651 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20651</ArticleId><ArticleId IdType="pmc">PMC4742957</ArticleId><ArticleId IdType="pubmed">26847824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann M. et al.. IFNalpha enhances the production of IL-6 by human neutrophils activated via TLR8. Sci Rep 6, 19674, doi: 10.1038/srep19674 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep19674</ArticleId><ArticleId IdType="pmc">PMC4726390</ArticleId><ArticleId IdType="pubmed">26790609</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz G. et al.. Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84&#x2013;87 in T cell allorecognition and peptide binding. Int Immunol 15, 565&#x2013;576 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12697658</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevanovic S. et al.. HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion. Blood 122, 1963&#x2013;1973, doi: 10.1182/blood-2012-12-470872 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-12-470872</ArticleId><ArticleId IdType="pubmed">23777765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauterbach N. et al.. Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain. Mol Immunol 59, 19&#x2013;29, doi: 10.1016/j.molimm.2013.12.006 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2013.12.006</ArticleId><ArticleId IdType="pubmed">24462895</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X., Ma Y., Cui W. &amp; Li M. D. Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes. Amino Acids 46, 1819&#x2013;1826, doi: 10.1007/s00726-014-1767-2 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-014-1767-2</ArticleId><ArticleId IdType="pubmed">24846544</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L. et al.. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 55, 1426&#x2013;1431, doi: 10.1002/hep.24799 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.24799</ArticleId><ArticleId IdType="pubmed">22105689</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien T. R. et al.. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun 12, 428&#x2013;433, doi: 10.1038/gene.2011.11 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2011.11</ArticleId><ArticleId IdType="pmc">PMC3169805</ArticleId><ArticleId IdType="pubmed">21346778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumasaka N., Nakamura Y. &amp; Kamatani N. The textile plot: a new linkage disequilibrium display of multiple-single nucleotide polymorphism genotype data. PloS one 5, e10207, doi: 10.1371/journal.pone.0010207 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010207</ArticleId><ArticleId IdType="pmc">PMC2860502</ArticleId><ArticleId IdType="pubmed">20436909</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>